Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18F2N2O6S2 |
InChIKeySHWNKRPMUBFWKE-UHFFFAOYSA-N |
CAS Registry1186654-00-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 08 May 2013 |